Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Shares Outstanding (2016 - 2017)

Bone Biologics (BBLG) has disclosed Shares Outstanding for 1 consecutive years, with $3.9 million as the latest value for Q4 2016.

  • On a quarterly basis, Shares Outstanding changed N/A to $3.9 million in Q4 2016 year-over-year; TTM through Dec 2016 was $3.9 million, a N/A change, with the full-year FY2016 number at $3.9 million, changed N/A from a year prior.
  • Shares Outstanding was $3.9 million for Q4 2016 at Bone Biologics.
  • In the past five years, Shares Outstanding ranged from a high of $3.9 million in Q4 2016 to a low of $3.9 million in Q4 2016.